Global Antibiotic R&D Partnership (GARDP)

Survive and thrive: Improving the global AMR response for healthier children and newborns.  Antimicrobial resistance (AMR) poses a significant threat to children's survival and health worldwide, with 1 out of every 5 deaths due to AMR occurring in children under the age of five.  Even though children are disproportionately affected by drug-resistant infections, they are being left behind in the current global AMR response.  GARDP's paediatric policy paper examines the reasons for this situation and provides recommendations to put children at the centre of our AMR response.  “Newborns in many African countries are disproportionately affected by drug-resistant infections. We hope GARDP’s work will ultimately lead to a better outcome for newborns so that they are able to survive and thrive.” Professor Ntobeko Ntusi – President and CEO of the South African Medical Research Council, which supports GARDP’s neonatal sepsis programme Learn more: https://lnkd.in/dc7w_yBM #AMR #PolicyPaper #AntibioticResistance #ChildrenHealth #SurviveAndThrive 

World AMR Awareness Week: Advocate for Action! At GARDP we know that antimicrobial resistance (AMR) knows no borders, affecting anyone, anywhere. Real-life stories from survivors, doctors or advocates are a powerful reminder of the human impact of AMR. Together we must push for bold policies, increased innovation in research and development, and global collaboration to ensure accessible and effective treatments for all. This #WAAW, join us in advocating for urgent, coordinated action to ensure a healthier tomorrow. #Advocate #WAAW2024 #AMRAwareness #GlobalHealth #AMR #AntibioticResistance

On World Children's Day we are reminded of the importance of prioritizing children's health. AMR places our youngest at high risk of serious bacterial infections, especially in low- and middle-income countries where the lack of access to effective treatments is a reality. At GARDP, we are listening to the needs of future generations by focusing on public health-driven R&D and advocating for equitable access to lifesaving and essential antibiotic treatments. “Public health-driven R&D and access is what we need, not just for antibiotics but for all conditions that affect children.” Dr Manica Balasegaram We believe that together, we can help children not only survive but thrive. Read our recommendations: https://lnkd.in/dc7w_yBM Read the latest GAP-f report: https://lnkd.in/dpgyaqBr #WAAW2024 #PowerOfAntibiotics #WorldChildrensDay #AMR

World AMR Awareness Week (WAAW) is here! This year's theme is a call to Educate, Advocate and Act now to address the urgent global health crisis of antimicrobial resistance (AMR). Education is our first line of defense, and at GARDP, we're committed to raising awareness about the dangers of AMR and the actions that can be taken to prevent and tackle it. This WAAW, let’s commit to deepening our understanding of AMR and sharing this knowledge within our communities. Together, we can prevent the misuse of antibiotics and preserve their effectiveness for future generations. #Educate #WAAW2024 #AntibioticAwareness #GlobalHealth #AMR #WAAW

Welcome to the GARDP discovery hub In its Discovery and Exploratory Research (DER) programme, GARDP aims to discover and deliver novel preclinical candidates to address urgent needs for solutions against antibacterial resistance. During the ESCMID/ASM conference, Benjamin Blasco highlighted our model of global collaboration in discovery and exploratory research. By partnering with academic institutions and industry leaders worldwide, we aim to drive impactful solutions and advance the fight against antibacterial resistance. Watch his presentation for insights into the DER's five research areas: https://lnkd.in/dvwVd2WT #AMR #PowerOfAntibiotics #ResearchAndDevelopment #Research #Antibiotics ESCMID - European Society of Clinical Microbiology and Infectious Diseases

🕒 The countdown to World Antimicrobial Awareness Week (WAAW) 2024 has begun! In just 5 days we will kick-off #WAAW2024, a week dedicated to raising awareness about the urgent global crisis of antimicrobial resistance (AMR). This year, let’s come together to Educate, Advocate, and Act now against AMR. Join us as we push for responsible antibiotic use, greater awareness, increased innovation in research and development, and global collaboration to ensure accessible and effective treatments for all. See you in 5 days! #WAAW #Healthcare #AMR #PowerOfAntibiotics

Don’t miss our last REVIVE webinar of 2024! Prof. Joy Lawn, Dr. Malabika Sarker, and Christine Halleux will share their insights on "Implementation research for the appropriate use of, and access to, antimicrobials". 🗓️ Date: 3 December 2024, 17 - 18:30 CET 🔗 Free registration: https://lnkd.in/drhH7Cpp #REVIVE #Webinar #AntibioticRD #ResearchAndDevelopment

Help us name this superbug! 🦠 Drug-resistant Acinetobacter baumannii is one of the most versatile and opportunistic pathogens found in healthcare settings, and it is now a major concern for hospital-acquired infections. Yet its difficult-to-pronounce name doesn't do justice to the serious threat it poses. Help us take down this superbug by giving it a name! Comment below with your fierce and creative ideas 👇 #AMR #AntibioticResistance #PowerOfAntibiotics

This recent study co-authored by our Global Access Director Jennifer Cohn investigates the effect of shortages on health systems and patient outcomes With the lack of access to safe and effective antibiotics contributing to the emergence and spread of antimicrobial resistance (AMR), this study  highlights how economic viability and reliance on single-source ingredients are key drivers of antibiotic shortages. Read more about "A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages": https://lnkd.in/dshtJsPh

GARDP in the Lancet! This new research focus article in The Lancet highlights GARDP's crucial role in fighting #AMR by advancing antibiotic development. “This is about business development for public health, not for commercial return” Dr Manica Balasegaram Read more about GARDP Executive Director, Manica Balasegaram's views on one of the biggest concerns is ensuring that public health remains at the forefront of their objectives: https://lnkd.in/dEDkX6ev #antibiotics #PowerOfAntibiotics #AMR #AntibioticDevelopment